Companies ›Consumer Non Cyclicals ›9305.T

9305.T — Tokyo Stock Exchange Food Retail & Distribution

9305.T

¥2 025,00

Open in Charts → Attach watcher ⌖

— —

JPY

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

3,35 %

Op margin

4,6 %

ROE

5,3 %

Net margin

3,8 %

Debt / equity

1,32

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

5,3 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 9305.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 9305.T. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

AI synthesis

GENERATED

The company maintains a capital structure with a debt-to-equity ratio of 1.32, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 0.67, suggesting potential short-term liquidity constraints. The company reported negative free cash flow of -4.55 billion JPY, driven by capital expenditures of -10.70 billion JPY, which exceeded operating cash flow of 5.80 billion JPY.

Profitability metrics show a return on equity of 5.3% and a return on assets of 1.85%, both below the typical thresholds for high-performing firms in the retail sector. The operating margin, calculated as operating income of 3.75 billion JPY on revenue of 80.92 billion JPY, is 4.64%, which is relatively low compared to industry benchmarks.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes.

The company's growth trajectory is modest, with no significant revenue growth reported in the latest period. The operating income of 3.75 billion JPY and net income of 3.09 billion JPY indicate stable but not robust performance.

Risk factors include a medium liquidity risk due to the current ratio of 0.67 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution events reported in the latest financial data.

Recent events include the filing of the latest financial report, which disclosed the company's financial performance and capital structure. No significant earnings call transcripts or regulatory filings were reported in the latest period.

Key takeaways

The company has a moderate debt-to-equity ratio of 1.32, indicating a balanced but not overly leveraged capital structure.
The company's liquidity position is weak, with a current ratio of 0.67 and negative free cash flow.
Profitability metrics are below industry benchmarks, with a return on equity of 5.3% and a return on assets of 1.85%.
The company's revenue is concentrated in a single business segment, increasing exposure to regional and regulatory risks.
The company's growth trajectory is modest, with no significant revenue growth reported in the latest period.
The company's dilution risk is low, with no significant dilution events reported in the latest financial data.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

¥2 025,00

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

¥58.38B

Net cashⓘ

-¥72.18B

Current ratioⓘ

0.7

Debt / equityⓘ

1.3

ROAⓘ

1.8%

ROEⓘ

5.3%

Cash conversionⓘ

188.0%

CapEx / revenueⓘ

-13.2%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin4,6 %Above median

Net Margin3,8 %Above median

ROE5,3 %Above median

Capex / Rev-13,2 %Bottom quartile

D/E1,32Bottom quartile

Cash Conv1,88Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

9305.T Market data — financials · 2026-05-27
Yamatane Corp Market data — analyst estimates · 2026-05-27

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

9305.TCanonical

Tokyo Stock Exchange · JPY

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread